Key Details
Price
$245.01Annual ROE
233.63%Beta
0.10Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
June 13, 2014Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
VANCOUVER, BC / ACCESS Newswire / January 22, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) is excited to share that it has started its exploration campaign at the Los Chapitos Copper Project in Peru. This campaign is completely funded by a CAD$1.5 million earn-in payment from Camino's exploration partner, Nittetsu Mining Co., Ltd.
The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons to make the most of this tool.
VANCOUVER, BC / ACCESS Newswire / January 16, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is happy to share that, following its announcement on January 10, 2025, it will proceed with the consolidation of its common shares. This means that for every six common shares held before the consolidation, shareholders will receive one common share after the consolidation. The consolidation will start at market opening on Monday, January 20, 2025.
The GARP strategy allows investors to invest in stocks that have great potential while being priced lower than their value. Some promising stocks include OUT, COR, RJF, and RMD.
VANCOUVER, BC / ACCESSWIRE / January 10, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") has announced that it has restructured its earlier planned C$2 million non-brokered private placement after talks with the TSX Venture Exchange (the "TSXV"). Additionally, the Company plans to consolidate its common shares on a 6:1 basis, which should happen before the Financing is finalized, pending approval from the TSXV.
Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.
COR has successfully acquired Retina Consultants of America, which is an important move to enhance its specialty healthcare and MSO services.
On Thursday, the drug distributor Cencora increased its forecast for annual adjusted profits.
Cencora, Inc. (NYSE: COR) has successfully completed its acquisition of Retina Consultants of America (RCA), a prominent management services organization for retina specialists. Cencora now holds about 85% of RCA, while some RCA doctors and management team members keep a small ownership stake in the company. Following this equity arrangement, RCA has received a cash investment.
Cencora (COR) has received a Zacks Rank #2 (Buy) upgrade, indicating increased confidence in the company's potential earnings. This could lead to a rise in the stock price soon.
FAQ
- What is the primary business of Cencora?
- What is the ticker symbol for Cencora?
- Does Cencora pay dividends?
- What sector is Cencora in?
- What industry is Cencora in?
- What country is Cencora based in?
- When did Cencora go public?
- Is Cencora in the S&P 500?
- Is Cencora in the NASDAQ 100?
- Is Cencora in the Dow Jones?
- When does Cencora report earnings?
- Should I buy Cencora stock now?